BAKER TILLY WEALTH MANAGEMENT, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
BAKER TILLY WEALTH MANAGEMENT, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$83,000
-34.6%
20,201
-43.1%
0.01%
-35.7%
Q4 2021$127,000
+154.0%
35,473
+156.9%
0.01%
+100.0%
Q3 2021$50,00013,8090.01%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders